Clinical Trial: Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli
Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Efficacy and Safety of Colistin for Therapy of Infections Caused by Extended Spectrum Beta-Lactamase(ESBL) Producing Klebsiella Pneumoniae or Escherichia Coli
Brief Summary: In patients with documented ESBL-producing E.coli and Klebsiella pneumoniae will be allocated to receive colistin or conventional antibiotic regimen.
Detailed Summary: In patients with documented ESBL-producing E.coli and Klebsiella pneumoniae will be allocated to receive colistin or conventional antibiotic regimen.The primary outcome is clinical response and secondary outcomes are microbiological response and adverse events.
Sponsor: Mahidol University
Current Primary Outcome: Clinical response
Original Primary Outcome: Same as current
Current Secondary Outcome: Microbiological response
Original Secondary Outcome: Same as current
Information By: Mahidol University
Dates:
Date Received: March 7, 2006
Date Started: February 2006
Date Completion: December 2006
Last Updated: May 19, 2006
Last Verified: March 2006